The kinetics and mechanisms of the reaction of Mesna with cisplatin, oxiplatin and carboplatin

Anticancer Research

Volumn 21, Issue 2 A, 2001, Pages 1225-1230

  Oprea, A ^a   Bazzazi, H ^a   Kangarloo, B ^a   Wolff, J E A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cisplatin Mesna binding, CarbopIatin Mesna binding, Oxiplatin Mesna binding

Indexed keywords

CARBOPLATIN; CISPLATIN; MESNA; OXALIPLATIN;

ARTICLE; BINDING KINETICS; CONCENTRATION RESPONSE; DRUG BINDING; DRUG MIXTURE; MATHEMATICAL MODEL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CALIBRATION; CARBOPLATIN; CISPLATIN; KINETICS; MESNA; MOLECULAR STRUCTURE; ORGANOPLATINUM COMPOUNDS; PLATINUM COMPOUNDS; PYRIDINES;

EID: 0035000494     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Prospective validation of a pharmacologically based dosing scheme for the cisdiamminechloroplatinum (II) analogue diamminecyclobutane dicarboxylatoplatinum
2. Interaction of aquated cis NHPtII with nucleic acid constituents: I.Ribonucleosides
3. Cisplatin- and Carboplatin-DNA adducts: Is Pt-AG the cytotoxic lesion?
4. Effects of thaliblastine on cytotoxicity and DNA damage in drug sensitive and resistant rat ovarian tumor treated with cisplatin
5. Aqueous platinum (II) chemistry: Binding to biological molecules
6. Cellular accumulation determines the activity of three novel platinum agents
7. The addition of etoposide and ifosfamide to Cisplatin as second line therapy in ovarian carcinoma
8. Protective effect of Sodium-2- mercaptoethane sulfonate on the gastrointestinal toxicity and lethality of cis-diammine dichloroplatinum
9. Oxazaphosphorine toxicity reduction by Mesna
10. Chemoprotectants for cancer chemotherapy
11. Effective prevention of nephrotoxicity of cisplatin (CDDP) by administration of sodium 2-mercaptoethane-sulphonate (MESNA) in rats
12. Megna Inactivates Platinum Agents in vitro
13. Reaction kinetics of Cisplatin and its monoaquated species with the modulating agents (Di) Mesna and Thiosulphate
14. Effects of fosfomycyn, Mesna and sodium thiosulphate on the toxicity and antitumor activity of Cisplatin
15. Platinum -DNA adduct formation in leukocytes of children in relation to pharmakokinetics after Cisplatin and Carboplatin therapy
16. Effects of Sodium Thiosulfate on the pharmakokinetics and on the distribution of platinum species in rat kidney: Protective mechanism against cisplatin nephrotoxicity
17. Pharmakokinetics and metabolism of sodium 2- meercaptoethanesulfonate in the rat
18. Application of DMSO Acidities to the Wittig Reaction with 6-Deoxy-6-formyl-β-cyclodextrin
19. Interaction between Cisplatin and Mesna in mice
20. Decomposition kinetics of Cisplatin in human biological fluids
21. Pharmacokinetics of mesna and dimesna after simultaneous intravenous bolus and infusion administration in patients undergoing bone marrow transplantation
22. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects
23. Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione